Cold-pressed wellness shots maker Vive Organic has secured $13m in Series B funding round led by Monogram Capital.

Other investors that participated in the funding round included Cambridge SPG and Powerplant Ventures.

The capital will be used for its digital footprint expansion and increase the accessibility of its plant-powered products.

Speaking of the development, Vive Organics co-founder and CEO Wyatt Taubman said: “We feel so fortunate to have found such exceptional partners in Monogram, Cambridge SPG, Powerplant Ventures and our roster of investors.

“We have a powerful product that we believe in deeply, which is quickly becoming the go-to for immunity-boosting in lieu of other traditional beverages, powders and supplement solutions.

“We are very proud of what we’ve created and greatly value the expertise our investors will provide in this next stage of our business as we look to further develop our online offerings and find new, unique ways to connect with consumers at retail.”

Established in 2015, Vive Organic is a functional beverage brand that offers cold-pressed wellness shots, which is claimed to boost the immune system.

For producing its beverage products, Vive makes use of cold-pressed technology to extract juice from the roots, herbs and flowers.

It claims that all its beverages are organic, non-GMO, gluten-free and vegan.

Monogram Capital co-founder and partner Jared Stein said: “Vive has tapped into an incredible opportunity to provide consumers with sustainably sourced, functional products that promote and support wellness needs, whether that be targeting uses case for enhanced immunity, restoration, or energy.”